Related Experiment Video
Updated: May 22, 2026

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
Published on: December 29, 2016
Clinical and immunopathological features of Moyamoya disease
Runhua Lin1, Zeyu Xie, Jianfa Zhang
1Institute of Clinical Pathology & Department of Pathology, Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Background:
Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis or occlusion of the terminal portion of internal carotid arteries and the formation of a vascular network at the base of the brain. The pathogenesis of MMD is still unclear.
Methodology/Principal Findings:
We retrospectively analyzed clinical data for 65 consecutive patients with MMD in our institutions and evaluated the histopathological and immunohistochemical findings of intracranial vessels from 3 patients. The onset age distribution was found to have 1 peak at 40-49 year-old age group, no significant difference was observed in the female-to-male ratio (F/M = 1.2). Intracranial hemorrhage was the predominant disease type (75%). Positive family history was observed in 4.6% of patients. Histopathological findings were a narrowed lumen due to intimal fibrous thickening without significant inflammatory cell infiltration, and the internal elastic lamina was markedly tortuous and stratified. All 3 autopsy cases showed vacuolar degeneration in the cerebrovascular smooth muscle cells. Immunohistochemical study showed the migration of smooth muscle cells in the thickened intima, and aberrant expression of IgG and S100A4 protein in vascular smooth muscle cells. The Complement C3 immunoreactivity was negative.
Conclusion/Significance:
This study indicated that aberrant expression of IgG and S100A4 protein in intracranial vascular wall of MMD patients, which suggested that immune-related factors may be involved in the functional and morphological changes of smooth muscle cells, and finally caused the thickened intima. A possible mechanism is that deposits of IgG in the damaged internal elastic lamina may underlie the disruption of internal elastic lamina, which facilitated S100A4 positive SMCs migrated into intima through broken portions of the internal elastic lamina, resulting in lumen stenosis or occlusion, leading to compensatory small vessels proliferation.
Insights
Moyamoya disease involves abnormal IgG and S100A4 protein expression in brain vessels, suggesting immune factors contribute to smooth muscle cell changes and artery narrowing. This may explain the disease
Area of Science:
- Cerebrovascular disease research
- Immunopathology of vascular disorders
- Smooth muscle cell biology
Background:
- Moyamoya disease (MMD) is a progressive cerebrovascular condition.
- Characterized by internal carotid artery stenosis and basal brain collateral vessels.
- Its underlying pathogenesis remains largely unknown.
Purpose of the Study:
- To investigate the histopathological and immunohistochemical features of intracranial vessels in MMD patients.
- To explore potential molecular mechanisms contributing to MMD development.
Main Methods:
- Retrospective analysis of clinical data from 65 MMD patients.
- Histopathological and immunohistochemical examination of intracranial vessels from 3 autopsy cases.
- Evaluation of smooth muscle cell changes, IgG, S100A4, and Complement C3 expression.
Main Results:
- MMD onset peaks between 40-49 years; female-to-male ratio is 1.2.
- Intracranial hemorrhage is the primary presentation (75%).
- Histopathology shows intimal thickening, tortuous internal elastic lamina, and vacuolar degeneration; IgG and S100A4 protein are aberrantly expressed in vascular smooth muscle cells.
Conclusions:
- Aberrant IgG and S100A4 protein expression in MMD intracranial vessels suggests immune involvement.
- A proposed mechanism involves IgG deposits disrupting the internal elastic lamina, promoting S100A4-positive smooth muscle cell migration and intimal thickening.
- This process may lead to lumen stenosis, occlusion, and compensatory neovascularization.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
